Elevated serum homocysteine levels for gouty patients

Clinical Rheumatology

Volumn 24, Issue 2, 2005, Pages 103-106

  Cheng, Tien Tsai ^a,b   Lai, Han Ming ^b   Chang, Hsueh Wen ^c   Luo, Shue Fen ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Allopurinol; Gouty arthritis; Homocysteine

Indexed keywords

ALLOPURINOL; HOMOCYSTEINE; URIC ACID; URICOSURIC AGENT;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GOUT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAMPLE SIZE;

ADULT; ALLOPURINOL; ARTHRITIS, GOUTY; CASE-CONTROL STUDIES; GOUT SUPPRESSANTS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 17544377418     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0978-4     Document Type: Article

References (22)

1. McCully KS (1975) Homocysteine theory of arteriosclerosis. Atherosclerosis 22:215-227 1:CAS:528:DyaE28XhtVyh
2. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S (1999) Homocysteine and cardiovascular disease: A critical review of the epidemiologic evidence. Ann Intern Med 131:363-375 1:CAS:528:DyaK1MXmt1KqsL4%3D
3. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J, Rosenberg IH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348:1120-1124 10.1016/ S0140-6736(96)03032-2
4. Morgan SL, Baggott JE, Lee JY, Alarcon GS (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during long-term, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention. J Rheumatol 25:441-446 1:CAS:528:DyaK1cXitVGkt7s%3D
5. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95:1119-1121 1:STN:280:ByiB3cjlsVE%3D
6. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ (1993) Vitamin B12, vitamin B6 and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 57:47-53 1:STN:280:ByyC3c3pslw%3D
7. Hultberg B, Andersson A, Sterner G (1993) Plasma homocysteine in renal failure. Clin Nephrol 40:230-234 1:STN:280:ByuD1cvpvVY%3D
8. Haagsma CJ, Blom HJ, Piet LCM van Riel, van't Hof MA, Giesendorf BAJ, Oppenraaij-Emmerzaal DV et al (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79-84 1:CAS:528:DyaK1MXitVynu7c%3D
9. Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J et al (1997) Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40:718-722 1:STN:280:ByiB2cvjtVI%3D
10. Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y et al (2000) Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol 10:403-409 1:STN:280:DC%2BD3M7ktFaksw%3D%3D
11. Fessel WJ (1980) High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med 68:401-404 10.1016/ 0002-9343(80)90111-4
12. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895-900 1:STN:280:CSiC1c7mtFA%3D
13. Istok R, Kovalancik M, Rovensky J (1999) Total plasma homocysteine in patients with gout. J Rheumatol 26:2068-2069 1:STN:280:DyaK1MvitFCnsQ%3D%3D
14. Cheng TT, Chiu CK (2002) Elevated homocysteine levels in patients with Raynaud's phenomenon secondary to systemic lupus erythematosus. Clin Rheumatol 21:251-254
15. Tsutsumi Z, Moriwaki Y, Yamamoto T, Takahashi S, Hada T (2002) Total plasma homocysteine is not increased in Japanese patients with gout. J Rheumatol 29:1805-1806 12180754
16. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al (1995) A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113 1:CAS:528:DyaK2MXlsVymt78%3D
17. Ho CH (2000) Prevalence of prothrombin 20210A allele and methylenetetrahydrofolate reductase C677T genetic mutations in the Chinese population. Ann Hematol 79:239-242 10.1007/s002770050586
18. Lwin H, Yokoyama T, Date C, Yoshiike N, Kokubo Y, Tanaka H (2002) Are the associations between life-style related factors and plasma total homocysteine concentration different according to polymorphism of 5,10-methylenetetrahydrofolate reductase gene (C677T MTHFR)? A cross-sectional study in a Japanese rural population. J Epidemiol 12:126-135 12033523
19. Emmerson B (1998) Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 57:509-510 1:STN:280:DyaK1M%2Fms1Wlug%3D%3D
20. Vuorinen-Markkola H, Yki-Jarvinen H (1994) Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 78:25-29
21. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N et al (2001) Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome: The Framingham offspring study. Diabetes Care 24:1403-1410 1:CAS:528:DC%2BD3MXmtlGitrc%3D
22. Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R (2003) Abnormal vitamin B(6) status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 114:283-287 10.1016/ S0002-9343(02)01528-0